OraSure Technologies ROE 2010-2025 | OSUR
Current and historical return on equity (ROE) values for OraSure Technologies (OSUR) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| OraSure Technologies ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2025-06-30 |
$-0.05B |
$0.38B |
-12.90% |
| 2025-03-31 |
$-0.03B |
$0.40B |
-7.96% |
| 2024-12-31 |
$-0.02B |
$0.41B |
-4.98% |
| 2024-09-30 |
$0.01B |
$0.43B |
2.34% |
| 2024-06-30 |
$0.03B |
$0.43B |
6.16% |
| 2024-03-31 |
$0.02B |
$0.43B |
5.31% |
| 2023-12-31 |
$0.05B |
$0.43B |
13.05% |
| 2023-09-30 |
$0.05B |
$0.41B |
12.59% |
| 2023-06-30 |
$0.04B |
$0.39B |
11.78% |
| 2023-03-31 |
$0.03B |
$0.39B |
8.31% |
| 2022-12-31 |
$-0.02B |
$0.36B |
-4.81% |
| 2022-09-30 |
$-0.04B |
$0.34B |
-12.01% |
| 2022-06-30 |
$-0.06B |
$0.34B |
-17.32% |
| 2022-03-31 |
$-0.05B |
$0.37B |
-11.96% |
| 2021-12-31 |
$-0.02B |
$0.38B |
-5.58% |
| 2021-09-30 |
$-0.01B |
$0.39B |
-2.51% |
| 2021-06-30 |
$0.01B |
$0.41B |
1.50% |
| 2021-03-31 |
$0.00B |
$0.40B |
-0.76% |
| 2020-12-31 |
$-0.01B |
$0.40B |
-3.84% |
| 2020-09-30 |
$-0.01B |
$0.39B |
-4.10% |
| 2020-06-30 |
$0.00B |
$0.38B |
-0.63% |
| 2020-03-31 |
$0.01B |
$0.29B |
4.05% |
| 2019-12-31 |
$0.02B |
$0.31B |
5.44% |
| 2019-09-30 |
$0.02B |
$0.30B |
8.33% |
| 2019-06-30 |
$0.02B |
$0.29B |
6.73% |
| 2019-03-31 |
$0.02B |
$0.28B |
6.87% |
| 2018-12-31 |
$0.02B |
$0.28B |
7.38% |
| 2018-09-30 |
$0.02B |
$0.28B |
6.42% |
| 2018-06-30 |
$0.02B |
$0.27B |
5.81% |
| 2018-03-31 |
$0.02B |
$0.26B |
6.43% |
| 2017-12-31 |
$0.03B |
$0.26B |
12.68% |
| 2017-09-30 |
$0.03B |
$0.25B |
13.73% |
| 2017-06-30 |
$0.03B |
$0.23B |
15.00% |
| 2017-03-31 |
$0.03B |
$0.21B |
15.68% |
| 2016-12-31 |
$0.02B |
$0.19B |
10.95% |
| 2016-09-30 |
$0.02B |
$0.18B |
10.19% |
| 2016-06-30 |
$0.01B |
$0.17B |
7.37% |
| 2016-03-31 |
$0.01B |
$0.16B |
6.23% |
| 2015-12-31 |
$0.01B |
$0.16B |
5.04% |
| 2015-09-30 |
$0.00B |
$0.16B |
0.00% |
| 2015-06-30 |
$0.00B |
$0.16B |
0.00% |
| 2015-03-31 |
$0.00B |
$0.16B |
0.63% |
| 2014-12-31 |
$-0.01B |
$0.16B |
-3.15% |
| 2014-09-30 |
$0.00B |
$0.16B |
2.51% |
| 2014-06-30 |
$0.00B |
$0.16B |
0.63% |
| 2014-03-31 |
$-0.01B |
$0.16B |
-4.47% |
| 2013-12-31 |
$-0.01B |
$0.16B |
-6.97% |
| 2013-09-30 |
$-0.02B |
$0.16B |
-14.38% |
| 2013-06-30 |
$-0.02B |
$0.16B |
-13.94% |
| 2013-03-31 |
$-0.02B |
$0.16B |
-14.57% |
| 2012-12-31 |
$-0.02B |
$0.17B |
-11.03% |
| 2012-09-30 |
$-0.01B |
$0.18B |
-7.59% |
| 2012-06-30 |
$-0.01B |
$0.10B |
-11.14% |
| 2012-03-31 |
$-0.01B |
$0.10B |
-9.07% |
| 2011-12-31 |
$-0.01B |
$0.10B |
-9.05% |
| 2011-09-30 |
$-0.01B |
$0.10B |
-9.98% |
| 2011-06-30 |
$-0.01B |
$0.10B |
-5.88% |
| 2011-03-31 |
$-0.01B |
$0.10B |
-4.89% |
| 2010-12-31 |
$0.00B |
$0.10B |
-3.90% |
| 2010-09-30 |
$-0.01B |
$0.10B |
-5.84% |
| 2010-06-30 |
$0.00B |
$0.10B |
-3.86% |
| 2010-03-31 |
$-0.01B |
$0.10B |
-7.71% |
| 2009-12-31 |
$-0.01B |
$0.10B |
-7.62% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Products Manufacturing |
$0.241B |
$0.186B |
|
OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices.
|
